Bionomics Acquires US-Based Cancer Stem Cell Company Eclipse Therapeutics
Acquisition provides Bionomics with cancer stem cell technology and antibody drug candidates
18-Sep-2012 -
Bionomics Limited has acquired San Diego-based private biotechnology company Eclipse Therapeutics Inc in a scrip-based US$10 million deal. With consideration of approximately 23.9 million shares at 41.76 cents per share, Eclipse shareholders, that include NASDAQ-listed Biogen Idec, will own ...